| Dr Dilip Rathinasamy, MD | |
|
403 Vonderburg Dr, Brandon, FL 33511-5982 | |
| (813) 681-1122 | |
| (813) 684-4924 |
| Full Name | Dr Dilip Rathinasamy |
|---|---|
| Gender | Male |
| Speciality | Ophthalmology |
| Experience | 21 Years |
| Location | 403 Vonderburg Dr, Brandon, Florida |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1750594628 | NPI | - | NPPES |
| 000121500 | Medicaid | FL |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207W00000X | Ophthalmology | ME98257 (Florida) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Gregory L Henderson Md Facs Inc | 9739172321 | 30 |
News Archive
Sonomax Hearing Healthcare Inc. (TSX Venture: SHH) announces that it has signed a five year licensing agreement with a newly formed Dutch company which has adopted the name Sonomax Europe BV (hereafter SEBV) with Sonomax's approval. Sonomax is not a stakeholder in SEBV.
It's the most common bacteria-related sexually transmitted disease in the United States, so researchers at The University of Texas at San Antonio's South Texas Center for Emerging Infectious Diseases (STCEID) and The University of Texas at San Antonio Health Science Center have partnered to discover a vaccine that will prevent Chlamydia.
Biogen Idec Inc. has reported success in a late stage clinical trial of its oral multiple sclerosis drug BG-12, a competitor's of Teva Pharmaceutical Industries' Laquinimod. A 240-milligram dose of BG-12 administered two or three times a day significantly reduced the proportion of patients who relapsed by 49% and 50%, respectively, after two years compared with a placebo.
A team of researchers from the University of Utah and Brigham Young University has developed a mouse model of focal dermal hypoplasia, a rare human birth defect that causes serious skin abnormalities and other medical problems. This animal model not only provides insight into studying the cause of focal dermal hypoplasia (FDH), but also offers a novel way to study a signaling pathway that is crucial for embryonic development.
The novel coronavirus 2019-nCoV is making headlines worldwide. Since there is no specific therapy against it, the prevention of infection is of particular importance in order to stem the epidemic.
› Verified 3 days ago
| Entity Name | Gregory L Henderson Md Facs Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1306839725 PECOS PAC ID: 9739172321 Enrollment ID: O20040722001097 |
News Archive
Sonomax Hearing Healthcare Inc. (TSX Venture: SHH) announces that it has signed a five year licensing agreement with a newly formed Dutch company which has adopted the name Sonomax Europe BV (hereafter SEBV) with Sonomax's approval. Sonomax is not a stakeholder in SEBV.
It's the most common bacteria-related sexually transmitted disease in the United States, so researchers at The University of Texas at San Antonio's South Texas Center for Emerging Infectious Diseases (STCEID) and The University of Texas at San Antonio Health Science Center have partnered to discover a vaccine that will prevent Chlamydia.
Biogen Idec Inc. has reported success in a late stage clinical trial of its oral multiple sclerosis drug BG-12, a competitor's of Teva Pharmaceutical Industries' Laquinimod. A 240-milligram dose of BG-12 administered two or three times a day significantly reduced the proportion of patients who relapsed by 49% and 50%, respectively, after two years compared with a placebo.
A team of researchers from the University of Utah and Brigham Young University has developed a mouse model of focal dermal hypoplasia, a rare human birth defect that causes serious skin abnormalities and other medical problems. This animal model not only provides insight into studying the cause of focal dermal hypoplasia (FDH), but also offers a novel way to study a signaling pathway that is crucial for embryonic development.
The novel coronavirus 2019-nCoV is making headlines worldwide. Since there is no specific therapy against it, the prevention of infection is of particular importance in order to stem the epidemic.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Dilip Rathinasamy, MD 307 S Bungalow Park Ave, Unit B, Tampa, FL 33609-3159 Ph: (813) 878-2020 | Dr Dilip Rathinasamy, MD 403 Vonderburg Dr, Brandon, FL 33511-5982 Ph: (813) 681-1122 |
News Archive
Sonomax Hearing Healthcare Inc. (TSX Venture: SHH) announces that it has signed a five year licensing agreement with a newly formed Dutch company which has adopted the name Sonomax Europe BV (hereafter SEBV) with Sonomax's approval. Sonomax is not a stakeholder in SEBV.
It's the most common bacteria-related sexually transmitted disease in the United States, so researchers at The University of Texas at San Antonio's South Texas Center for Emerging Infectious Diseases (STCEID) and The University of Texas at San Antonio Health Science Center have partnered to discover a vaccine that will prevent Chlamydia.
Biogen Idec Inc. has reported success in a late stage clinical trial of its oral multiple sclerosis drug BG-12, a competitor's of Teva Pharmaceutical Industries' Laquinimod. A 240-milligram dose of BG-12 administered two or three times a day significantly reduced the proportion of patients who relapsed by 49% and 50%, respectively, after two years compared with a placebo.
A team of researchers from the University of Utah and Brigham Young University has developed a mouse model of focal dermal hypoplasia, a rare human birth defect that causes serious skin abnormalities and other medical problems. This animal model not only provides insight into studying the cause of focal dermal hypoplasia (FDH), but also offers a novel way to study a signaling pathway that is crucial for embryonic development.
The novel coronavirus 2019-nCoV is making headlines worldwide. Since there is no specific therapy against it, the prevention of infection is of particular importance in order to stem the epidemic.
› Verified 3 days ago
David S Nichols, M.D. Ophthalmology Medicare: Not Enrolled in Medicare Practice Location: 403 Vonderburg Dr, Ste 101, Brandon, FL 33511 Phone: 813-681-1122 Fax: 813-684-4924 | |
William A Reeves, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 403 Vonderburg Dr, Brandon, FL 33511 Phone: 813-681-1122 Fax: 813-684-4924 | |
Dr. Michael Anthony Lopez, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 403 Vonderburg Dr, Brandon, FL 33511 Phone: 813-681-1122 Fax: 813-684-4924 | |
Dr. Ronni M Chen, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 403 Vonderburg Dr, 101, Brandon, FL 33511 Phone: 813-681-1122 Fax: 813-684-4924 | |
Jose Perez Gonzalez De Apodaca, M.D./PH.D Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 206 Buckingham Pl Ste 102, Brandon, FL 33511 Phone: 813-653-2020 Fax: 813-653-2205 | |
Mr. Byron Edward Holley, M.D. Ophthalmology Medicare: Not Enrolled in Medicare Practice Location: 1011 Cherwood Ln, Brandon, FL 33511 Phone: 813-681-1456 Fax: 813-684-6451 | |
Dr. Jennifer Sara Landy, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 540 Medical Oaks Ave Ste 103, Brandon, FL 33511 Phone: 813-684-2211 Fax: 813-685-0895 |